By Regulatory Approvals — FDA Clears Prelude’s PRT13722 Phase 1 Trial in HR-Positive Breast Cancer The Clinical Trial Vanguard
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. September 11, 2026.